🇺🇸 FDA
Pipeline program

BBO-10203

TBBO10203-101

Phase 1 small_molecule active

Quick answer

BBO-10203 for Solid Tumor, Adult is a Phase 1 program (small_molecule) at BridgeBio Oncology Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
BridgeBio Oncology Therapeutics
Indication
Solid Tumor, Adult
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials